Abstract

Objective: Flavonoids, naturally-occurring compounds in fruits and vegetables, possess anti-coagulant property. However, a very few studies wereattempted to understand how flavonoid structure influences its anti-coagulation property, such as clotting time. In this study, we investigatedstructurally similar flavonoid compounds which differ in the number of hydroxyl groups and compared their anti-coagulation properties.Methods: We selected and evaluated five flavonoid compounds, that is, chrysin, apigenin, luteolin, kaempferol, and quercetin, for their anti-coagulantproperties using in vitro prothrombin time (PT) assays and activated partial thromboplastin time (APTT) assay.Results: Our findings suggested that quercetin, kaempferol, and luteolin showed a significant anti-coagulant effect on APTT (p<0.05) in a dosedependentmanner. The dose of 500 μM quercetin showed potent prolong APTT with 37.43±1.60 s, followed by 500 μM of kaempferol and luteolin(34.63±1.29 s and 4.83±1.56 s, respectively). Furthermore, a combination of 500 μM of quercetin with 0.25 U/ml of heparin demonstrated prolongAPTT (52.16±5.18 s) when compared with individual effects of either 0.25 U/ml heparin (33.4±0.50 s) or 500 μM quercetin (37.43±1.62 s) alone.Conclusion: Our results demonstrated that numbers of the hydroxyl group on flavonoid compounds influence anti-coagulation properties. Inaddition, the prolonged APTT assay results suggested that quercetin, kaempferol, and luteolin could affect factors VIII, IX, XI, and XII of intrinsicpathway. Moreover, the synergistic effect of quercetin further enhances the heparin anti-coagulation effect. Based on our findings, we recommendthat the consumption of vegetables and fruits rich in quercetin, luteolin, and kaempferol could help prevent thrombotic stroke in high-risk patients.

Highlights

  • Non-communicable diseases, including diabetes mellitus (DM) and hypertension (HT), have been increased in both developing and developed countries [1]

  • We investigated anti-coagulant properties of flavonoids with different numbers of hydroxyl groups

  • Our results demonstrated anti-coagulant effect of luteolin, kaempferol, and quercetin on blood clotting through activated partial thromboplastin time (APTT) assay, but not prothrombin time (PT) assay

Read more

Summary

Introduction

Non-communicable diseases, including diabetes mellitus (DM) and hypertension (HT), have been increased in both developing and developed countries [1]. DM and HT are well-established risk factors for stroke, wherein pathological conditions worsen blood vessel damage and stimulate excessive blood clotting [2,3,4]. Two primary blood clotting pathways are (1) intrinsic pathway (factors VIII, IX, XI, and XII) and (2) extrinsic pathway (factor VII). Both pathways induce fibrin clot formation [5,6,7]. Patients with DM and HT are being treated with warfarin, heparin, and aspirin to prevent blood clotting and avoid life-threatening stroke condition [8]. Long-term use of these medical drugs on anti-coagulant treatment caused hemorrhagic risk [9]. This study was conducted to explore anti-coagulant ability of natural flavonoid compounds, and their potential being a safer alternative to prescribed anti-coagulant drugs

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call